8. How will COVID-19 affect the MSL role and what new skills may emerge as necessary to maintain value, access and future success with Paul Ward
My guest today is Paul Ward. He is the National Director, Oncology MSLs at AstraZeneca, and MSL Society Advisory Board Member. We will discuss how Covid-19 will affect the role of the MSL and what new skills may emerge as necessary to maintain value, access, and future success. In this episode: How interviews are being conducted during this time Considering the travel bans and limited access, what other activities should MSLs be focusing on during the pandemic? Skills mandatory for MSLs during and after the crisis to find success How has COVID 19 affected the hiring landscape and what is expected to happen in the upcoming months/year How will HCP expectations change as a result of Covid How an MSL can meet or exceed expectations during the pandemic How does Paul expect Pharma to change practices as a result of Covid-19 The advice Paul can give to MSLs to help aid in their success Paul Ward